Clinical Trials in Shanxi, China
Locations / Shanxi, China
Delta Trials catalogs 59 clinical trials conducted in Shanxi, China, making it a notable site of clinical research activity. These trials spanning 109 distinct medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 2 trials in this location were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations in Shanxi evolve over time.
59
Total Trials
109
Conditions
2
Terminated since 2020
Browse by condition (109 total)
- Non-small cell lung cancer 2 trialsAll Non-small cell lung cancer trials
- Diffuse large B-cell lymphoma 2 trialsAll Diffuse large B-cell lymphoma trials
- All Chronic obstructive pulmonary disease trials
- Hemophilia a with inhibitor 1 trialAll Hemophilia a with inhibitor trials
- All Macular edema secondary to retinal vein occlusion trials
- COPD 1 trialAll COPD trials
- Iron deficiency anemia 1 trialAll Iron deficiency anemia trials
- Primary immune thrombocytopenia 1 trialAll Primary immune thrombocytopenia trials
- Impairment, cognitive 1 trialAll Impairment, cognitive trials
- All Polypoidal choroidal vasculopathy (pcv) trials
- All Locally advanced or metastatic non-small cell lung cancer trials
- All Platinum sensitive ovarian cancer (psoc) trials
- Tnbc 1 trialAll Tnbc trials
- Waldenstrom macroglobulinemia 1 trialAll Waldenstrom macroglobulinemia trials
- Intracranial artery stenosis 1 trialAll Intracranial artery stenosis trials
- Influenza 1 trialAll Influenza trials
- Ulcerative colitis 1 trialAll Ulcerative colitis trials
- All Occlusion and stenosis of cerebellar arteries trials
- All Generalized convulsive status epilepticus trials
- All Immune-mediated necrotizing myopathy trials